15 November 2021

Bioglan and Stada partner to increase capacity to meet rising demand for Parkinson’s treatment

29 October 2021

Reig Jofre submits results note on third quarter of 2021

29 July 2021

Reig Jofre submits results note on second quarter of 2021

22 July 2021

Reig Jofre acquires 100% of REIG JOFRE UK LTD and consolidates its presence in the United Kingdom

21 July 2021

Start of the trading of the new shares within its scrip dividend

6 July 2021

Start of the second temporary share buyback program

6 July 2021

Increase in the bonus-share capital and new shares to be issued

5 July 2021

Completion of the liquidity contract

9 June 2021

Execution of the scrip dividend

4 June 2021

Conditions of the scrip dividend

11 May 2021

Changes in the Board of Directors

29 April 2021

Reig Jofre submits results note on the first quarter of 2021

26 April 2021

Date change for the release of the result note of 1Q 2021

20 April 2021

Reig Jofre opens a subsidiary in Poland

26 March 2021

Reig Jofre convenes its 2021 General Shareholders´ Meeting

26 February 2021

Reig Jofre submits results note on the fourth quarter of 2020

15 December 2020

Reig Jofre announces technology transfer of the large scale manufacturing in Spain for a Covid-19 vaccine candidate

13 November 2020

Reig Jofre submits results note on the third quarter of 2020

23 October 2020

Reig Jofre informs on the start date of the trading of the new shares within its scrip dividend

9 October 2020

Distribution of a dividend in the form of scrip dividend